New COVID Variant BA.3.2 Detected In US As Cases Rise

New COVID Variant BA.3.2 Detected In US As Cases Rise...

Health officials confirmed the first U.S. cases of the BA.3.2 COVID-19 variant this week as infections show an upward trend in several states. The variant, nicknamed "Cicada" by some researchers due to its sudden emergence, has raised concerns about potential immune evasion and transmissibility.

The Centers for Disease Control and Prevention (CDC) reported 127 BA.3.2 cases across 12 states as of March 30, with the highest concentrations in New York, California, and Florida. This comes as national COVID hospitalizations increased 14% over the past two weeks, though deaths remain near record lows.

Dr. Rochelle Walensky, CDC director, stated Wednesday that existing vaccines still provide protection against severe outcomes. However, preliminary data suggests BA.3.2 may spread 20-30% faster than the currently dominant JN.1 variant. The World Health Organization classified BA.3.2 as a "variant under monitoring" last week.

Pharmacies report increased demand for COVID tests in affected areas, though no major supply chain disruptions have occurred. Several school districts in New York and Massachusetts reinstated optional masking policies this week as a precaution.

The variant's emergence coincides with spring travel season, with health experts urging caution for high-risk individuals. Next-generation vaccines targeting newer variants are expected by fall 2026, according to Moderna and Pfizer executives.

Google search interest in "Cicada COVID variant" spiked 480% in the U.S. over the past 24 hours as news spread. Public health officials emphasize this isn't a return to pandemic-era restrictions, but recommend staying updated on boosters for vulnerable populations.